---
$id: https://graph.org.ai/products/commodity/51161711
$type: Product
source: UNSPSC
code: "51161711"
title: "Mepixanox"
class: "51161700"
classTitle: "Drugs used for respiratory tract disorders"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mepixanox

**UNSPSC Code**: 51161711
**Class**: [Drugs used for respiratory tract disorders](Drugs used for respiratory tract disorders.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C20H21NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7419T4YQQW, chemically known as 9h-xanthen-9-one, 3-methoxy-4-(1-piperidinylmethyl)- but generally known as mepixanox, which bears US NIH Compound Identifier 65687. European Medicines Agency schedules Mepixanox in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08754MIG. The term MEPIXANOX is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules mepixanox in its Anatomical Therapeutic Chemical (ATC) Classification. MEPIXANOX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule mepixanox under HS 29349990 and SITC 51579. As of Q4 2014, MEPIXANOX remains the US FDA Preferred Term for this commodity. Mepixanox bears US NLM identifiers UMLS ID C0071070 and NCI Concept Code C66094. SMILES: O1C2C(CN3CCCCC3)C(OC)CCC2C(=O)C2C1CCCC2.

